pyridinolcarbamate has been researched along with Prediabetic State in 1 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Prediabetic State: The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furitano, G | 1 |
| Paterna, S | 1 |
| Di Pasquale, P | 1 |
1 other study available for pyridinolcarbamate and Prediabetic State
| Article | Year |
|---|---|
[Rheographic normalization in prediabetic subjects treated with pyridinolcarbamate].
Topics: Adult; Blood Vessels; Carbamates; Female; Foot; Humans; Male; Plethysmography, Impedance; Prediabeti | 1978 |